SEI Investments’s Summit Therapeutics SMMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SMMT
BBA
KCM
SEI Investments's SMMT Position: Q3 2026 in Review
SEI Investments reduced its Summit Therapeutics (SMMT) stake by 54% in Q3 2026, selling an estimated $355K and leaving 20,386 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #2797.
SEI Investments first reported a position in SMMT in Q2 2023 and has held it in 11 quarters since. The position peaked at $642K in Q2 2026. 296 funds tracked by Wall St. Rank hold SMMT as of Q3 2026.
- SEI Investments held 20,386 shares of Summit Therapeutics worth $345K as of Q3 2026.
- SEI Investments sold 23,711 Summit Therapeutics shares in Q3 2026, an estimated $355K.
- Summit Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #2797 holding.
- SEI Investments first reported a position in Summit Therapeutics in Q2 2023 and has held it in 11 quarters since.
- SEI Investments's Summit Therapeutics position peaked at $642K in Q2 2026.
- 296 funds tracked by Wall St. Rank held Summit Therapeutics as of Q3 2026.
Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.